USA • New York Stock Exchange • NYSE:PHG • US5004723038
The current stock price of PHG is 29.46 USD. In the past month the price increased by 0.1%. In the past year, price increased by 7.99%.
ChartMill assigns a technical rating of 8 / 10 to PHG. When comparing the yearly performance of all stocks, PHG turns out to be only a medium performer in the overall market: it outperformed 55.56% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to PHG. While PHG is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months PHG reported a non-GAAP Earnings per Share(EPS) of 1.75. The EPS increased by 15.15% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.93% | ||
| ROA | 0.63% | ||
| ROE | 1.56% | ||
| Debt/Equity | 0.69 |
28 analysts have analysed PHG and the average price target is 32.34 USD. This implies a price increase of 9.78% is expected in the next year compared to the current price of 29.46.
For the next year, analysts expect an EPS growth of 4.94% and a revenue growth -2.27% for PHG
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.3 | 192.719B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.76 | 173.049B | ||
| SYK | STRYKER CORP | 23.7 | 137.017B | ||
| BSX | BOSTON SCIENTIFIC CORP | 21.78 | 113.066B | ||
| BDX | BECTON DICKINSON AND CO | 14.13 | 59.944B | ||
| IDXX | IDEXX LABORATORIES INC | 43.51 | 51.472B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.47 | 45.675B | ||
| RMD | RESMED INC | 22.12 | 39.65B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.06 | 36.738B | ||
| DXCM | DEXCOM INC | 27.71 | 27.29B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
KONINKLIJKE PHILIPS NVR- NY
High Tech Campus 5
Eindhoven NOORD-BRABANT 1096 BC NL
CEO: Frans van Houten
Employees: 67035
Phone: 31205977777
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. The company is headquartered in Eindhoven, Noord-Brabant and currently employs 67,035 full-time employees. The company went IPO on 2009-09-18. The firm's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.
The current stock price of PHG is 29.46 USD. The price increased by 2.01% in the last trading session.
KONINKLIJKE PHILIPS NVR- NY (PHG) has a dividend yield of 3.87%. The yearly dividend amount is currently 0.
PHG has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
KONINKLIJKE PHILIPS NVR- NY (PHG) will report earnings on 2026-02-10, after the market close.
You can find the ownership structure of KONINKLIJKE PHILIPS NVR- NY (PHG) on the Ownership tab.
The outstanding short interest for KONINKLIJKE PHILIPS NVR- NY (PHG) is 0.35% of its float.